NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Pre

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Preparing to Enter the Post-Surgical Pain Management Market through Proposed Merger

Research and development company Skinvisible (OTCQB: SKVI) previously announced the signing of a Letter of Intent for a proposed merger with Quoin Pharmaceuticals Limited, which would successfully mark the company’s entrance into the post-surgical pain management market. The partnership has the potential to address significant unmet medical needs on the pain management market. An article discussing the company’s endeavor reads: “Currently, the pain management market in the U.S. is fueled by a number of sectors. The most prominent ones include post-operative pain relief, arthritis pain, cancer pain, migraine and neuropathic pain. As larger Western populations age and become susceptible to an array of medical conditions, the need for new pain management developments will grow even further. The partnership between Skinvisible and Quoin perfectly positions the two companies to address these growing unmet needs on the pain management market.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer